COVID-19 associated pediatric complications: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 2: Line 2:
To go to the COVID-19 project topics list, click '''[[COVID-19 Project Topics|here]]'''.
To go to the COVID-19 project topics list, click '''[[COVID-19 Project Topics|here]]'''.


{{CMG}} {{AE}} {{HAR}} {{AIA}}
{{CMG}} {{AE}} {{HAR}}; {{AIA}}


==Overview==
==Overview==

Revision as of 08:26, 25 June 2020

To go to the COVID-19 project topics list, click here.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Harmeet Kharoud M.D.[2]; Abdelrahman Ibrahim Abushouk, MD[3]

Overview


Epidemiology and Demographics


Mode of transmission


Presentations

  • Presentation of COVID-19 is less severe in children as compared to adults.
  • According to CDC, as of April 2, 2020, 1.7% confirmed cases of COVID-19 were reported in children aged <18 years age among the total number of confirmed cases of COVID-19.
  • Illness severity of COVID-19 in children ranges from asymptomatic to critical.[1]
Symptoms
Clinical Course of COVID-19 in children.
  • Asymptomatic presentation-
    • Children present with no clinical signs or symptoms with normal chest imaging.[1]
    • Among 2143 children with COVID-19 infection 4% of children were asymptomatic.[1]
    • According to one study 14.2% of children were asymptomatic[2]. Another study showed 18% of asymptomatic children with COVID-19.
  • Mild Disease
    • Children present with mild symptoms including fever, fatigue, myalgia, cough.[1]
    • Among 2143 children with COVID-19 infection 51% of children had a mild disease of COVID-19.[1]
    • A study showed 36.3% of children present with a mild form of the disease[2].
  • Severe
    • Children present with dyspnea, central cyanosis, hypoxia.[1]
    • Among 2143 children with COVID-19 infection 5% of children had a severe presentation.[1]
    • 2.1% of children present with a severe form of COVID-19 disease[2].
    • Children with underlying comorbidities are more susceptible to getting severe COVID-19 disease.
  • Critical

Complications

Multisystem Inflammatory Syndrome in Children(MIS-C)
  • It is a condition that causes inflammation of some parts of the body like heart, blood vessels, kidneys, digestive system, brain, skin, or eyes.
  • According to recent evidence it is suggested that children with MISC had antibodies against COVID-19 suggesting children had COVID-19 infection in the past.

Symptoms

Emergency Warning Signs

Prevention of MIS-C

  • We could prevent MIS-c by preventing the child exposure to COVID-19 by taking necessary measures.

Complication 2

Diagnosis


Most of the children with SARS-CoV-2 infection are either asymptomatic or produce mild symptoms. As asymptomatic patients do not get tested for COVID-19 and are potential carriers for viral transmission, high clinical suspicion is required to prevent such transmissions to a population at risk of developing severe disease. A pediatrician should be cautious to eliminate other causes of respiratory illnesses like seasonal influenza before any diagnostic tests. No diagnostic test is required for a kid with mild illness and no history of exposure to SARS-CoV-2.

Reverse-Transcriptase Polymerase Chain Reaction

U.S. Food and Drug Administration (FDA) has approved real-time Reverse-Transcription Polymerase Chain Reaction (RT-PCR) as the preferred test for diagnosing COVID-19 in children

Lab abnormalities

Studies reportedly showed following lab abnormalities in pediatric patients with COVID-19 [2]

Co-infections

Co-infection with other pathogens were reported in 27% of cases[3]. Some common microorganisms associated with SARS-CoV-2 infection in children are

Radiological findings

CT chest is an important diagnostic modality in pediatric patients with COVID-19. Chest CT scans has reportedly shown higher positive rates in suspected patients than RT-PCR. It has better sensitivity. CT chest and a series of chest X-rays can be used to monitor the progression of the disease. Imaging findings reported in the studies are[2][3]

Children are at increased risk of radiation and its effects, so CT scans and X-rays should be judiciously used in them. It is advised to perform Pulmonary Ultrasonography (USG) in newborns. It has better sensitivity and is safer than CT scans and Chest X-rays.

Treatment


Prevention


References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 Eastin, Carly; Eastin, Travis (2020). "Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China". The Journal of Emergency Medicine. 58 (4): 712–713. doi:10.1016/j.jemermed.2020.04.006. ISSN 0736-4679.
  2. 2.0 2.1 2.2 2.3 2.4 de Souza TH, Nadal JA, Nogueira RJN, Pereira RM, Brandão MB (2020). "Clinical manifestations of children with COVID-19: A systematic review". Pediatr Pulmonol. doi:10.1002/ppul.24885. PMID 32492251 Check |pmid= value (help).
  3. 3.0 3.1 Zhang L, Peres TG, Silva MVF, Camargos P (2020). "What we know so far about Coronavirus Disease 2019 in children: A meta-analysis of 551 laboratory-confirmed cases". Pediatr Pulmonol. doi:10.1002/ppul.24869. PMC 7300763 Check |pmc= value (help). PMID 32519809 Check |pmid= value (help).